Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
22nd Annual Women’s Health Annual Visit (WHAV)
Multiple dates & locations available
Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
The 2-Point Signal: Apply ≥2-Point Rule
The IgG Clock: Redose Using IgG Kinetics
Shared Goals, Shared Gains: Align With Patient Preferences
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Target Locked in gMG: Why T2T Matters
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Turning Flares Into Function: Flag Uncontrolled Disease
FcRn: Same Class, Different Paths—Spot Agent Differentiators
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Samantha Denäe
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
James A. Simon, MD, CCD, NCMP, IF, FACOG
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Sawsan As-Sanie, MD
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
Pre- and Postoperative Use of GnRH Antagonists
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
When to Begin FcRn: Initiation Criteria, Key Evidence
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
The Alloimmune Disorders of Pregnancy
Clinical Considerations for the Diagnosis of Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.